Autologous Stem Cell Transplant in Lymphoma Using a Noncryopreserved Platform: An Adapted Sequential Conditioning...

Area of Science:

• Hematology
• Oncology
• Stem Cell Transplantation

Background:

• Autologous stem cell transplantation (ASCT) is a key therapy for lymphoma.
• Conventional conditioning regimens (e.g., CVB, BEAM, ICE) typically span 6-7 days.
• A shift towards noncryopreserved platforms necessitates shorter conditioning durations.

Purpose of the Study:

• To evaluate the outcomes of a modified, shorter (4-5 day) conditioning regimen for ASCT in lymphoma patients.
• To compare results before and after implementing a noncryopreserved platform in 2015.

Main Methods:

• Retrospective comparison of ASCT procedures performed between 2000-2014 (n=46) and 2015-2022 (n=61).
• Analysis focused on outcomes following a reduced-duration conditioning protocol (4-5 days) implemented in 2015.

Main Results:

• The modified regimen was associated with a higher number of infused stem cells.
• Significant reductions in febrile neutropenia (60% vs. 37%) and hospitalization duration (30 vs. 18 days) were observed.
• Faster engraftment (20 vs. 14 days) and improved progression-free survival (72 vs. 44 months) were noted.

Conclusions:

• Adjusted conditioning for noncryopreserved ASCT strategies yields comparable or superior outcomes to cryopreserved methods.
• The shortened conditioning protocol demonstrates efficacy in lymphoma treatment.
• Further prospective studies are recommended to validate these findings.